LONE TREE, Colo., Sept. 13, 2016 /PRNewswire/ --Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring, announces today August 2016 electrotherapy orders.
During the month of August, Zynex received 2,043 orders from clinics and patients for electrotherapy units. This is a 99% increase in orders compared to 1,028 orders in August of last year. The orders received were higher than estimated and represents a 7% increase over orders in July 2016.
Thomas Sandgaard, CEO commented: "We are currently receiving orders at a level twice the run rate of last year, demonstrating a strong and increasing demand for our NexWave device. However, current orders have stabilized at this level, primarily due to our capital constraints. We have the potential to grow significantly more but we are limited in our ability to build new products to keep up with patient orders and field demo units. We are diligently seeking additional funding to take advantage of the huge electrotherapy market potential where there is currently very little competition."
About Zynex
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex is also developing a new blood volume monitor for use in hospitals and surgery centers. For additional information, please visit: Zynex.com.
Safe Harbor Statement
Statements made in this presentation include financial estimates and forward-looking statements that are not historical facts. Each of these estimates and forward-looking statements involves risk and uncertainties. These estimates are based on present circumstances, information currently available, and assumptions about future revenues, industry growth, and general economic conditions. Estimates are inherently uncertain as they are based on assumptions concerning future events. No representations can be made as to the accuracy of such information or the reliability of such assumptions. Accordingly, actual revenues and expenditures may vary significantly from the Company's estimates, and actual results or developments may differ materially from those expressed or implied by the forward-looking statements. Factors that could cause actual results to differ from the financial estimates and forward-looking statements in this presentation include those described in the Company' s filings with the Securities and Exchange Commission, including the Risk Factors section of the Company's Annual Report on Form 10-K for the year ended December 31, 2015. Therefore, neither the Company's estimates nor the assumptions upon which they are based are to be interpreted as a guarantee or promise of the Company or management. The Company has no obligation to modify, amend, update, alter, or change the estimates contained herein.
Contact: Zynex, Inc. 303-703-4906
Logo - http://photos.prnewswire.com/prnh/20160531/373722LOGO
SOURCE Zynex
